drugset / Trial / NCT04262934

Does Correction of 25 OH-VITAmin D With Cholecalciferol Supplementation Increase Muscle Strength in hemoDIALysis Patients?

NCT04262934

Phase 3 Unknown 150 enrolled Institut Phoceen de Nephrologie
RandomizedParallel-groupOpen-labelTreatment

Summary

Muscle strength decreases as renal failure progresses. Low muscle strength affects more than 50% of hemodialysis patients and leads to daily life activities impairment. In the general population, numerous studies have linked low 25OH-vitamin D (25OHD) concentrations to the loss of the muscle strength and low physical performances. Data on native vitamin D and muscle function are scarce in the chronic renal failure (CKD) population, but low 25OHD levels have been associated with poor muscle strength. In this protocol of an ongoing study named VITADIAL testing if cholecalciferol supplementation in hemodialysis patients with low 25OHD improve their muscle strength.

Timeline

Start
2018-01-08
Primary completion
2024-06-08
Completion
2024-06-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 100000 iu Oral

Indications

No indication recorded.